Jeff Eiseman

Long only, deep value, special situations
Jeff Eiseman
Long only, deep value, special situations
Contributor since: 2013
10/1/14
Jeff Eiseman
The Cloud's Silver Lining: Beyond Tonix' Missed Phase 2 Primary Endpoint For Fibromyalgia $TNXP http://seekingalpha.com/a/1i8q7
10/1/14
Great article, thanks for sharing!
8/13/14
Jeff Eiseman
Properly Treating Costs: Re-Evaluating The MannKind And Sanofi Partnership $MNKD http://seekingalpha.com/a/1fvnf
8/12/14
Jeff Eiseman
What The Judge's Award Means For PharmAthene's Value/Share: A Data-Based Analysis $PIP http://seekingalpha.com/a/1fp0j
7/29/14
Jeff Eiseman
While We Wait For A Ruling In SIGA V. PharmAthene, One More Round With G. Hudson http://seekingalpha.com/a/1efm3
7/24/14
Jeff Eiseman
PharmAthene V. SIGA: Rebutting G. Hudson's 'Potential Award' Article $PIP, $SIGA http://seekingalpha.com/a/1e0wx
6/13/14
Jeff Eiseman
Do MannKind Insiders Harbor Doubts? Three Authors Say 'Yes'; I Say 'No.' $MNKD http://seekingalpha.com/a/1clut
5/14/14
Jeff Eiseman
How The Judge Will Arrive At A Remedy In SIGA V. PharmAthene http://seekingalpha.com/a/1bk01
4/2/14
Jeff Eiseman
Reconciling Rival Views Of Afrezza, And How To Play The Post-AdCom Surge $MNKD http://seekingalpha.com/a/19hp1
3/28/14
Jeff Eiseman
What The FDA Document Says About Afrezza: Implications For FDA Approval $MNKD http://seekingalpha.com/a/19c4r
3/24/14
Jeff Eiseman
Fear, Greed, And Prudent Risks: A Clarion Call To The Keepers Of The MannKind Flame $MNKD http://seekingalpha.com/a/19503
3/26/14
Normally, in psychological studies Greed wins over Fear, or not? Why the fear now?
3/6/14
Jeff Eiseman
How Will Subconscious Issues Influence FDA AdCom Voting On Afrezza? $MNKD http://seekingalpha.com/a/18eqt
1/22/14
Jeff Eiseman
MannKind Catalysts: Insights About Diabetes Care Metrics & Long-Term Complications $MNKD http://seekingalpha.com/a/15yxn
1/22/14
Excellent article -- separates wheat from chaff.